To date, the molecular mechanisms that underline aggressiveness and resistance to tyrosine kinase inhibitors in some thyroid carcinomas (TCs) are not known yet. We report the case of a young patient w

NIAID Data Ecosystem40

CNV and LOH analysis of patient sample PN11-0204

基因组变异检测

甲状腺癌分子病理

CNV and LOH analysis of patient sample PN11-0204

ChEBI2012-08-28 更新20

Characteristics of studies included in the meta-analysis.

甲状腺癌分子病理

癌症遗传变异

The Ho(a) investigated thyroid cancer, and the Ho(b) investigated salivary gland cancer. PB: population based; HB: hospital based; T-ARMS-PCR:tetra-primeramplification refractory mutation system PCR;

NIAID Data Ecosystem60

Overall concordance obtained between different experiments undertaken in dysplastic lesions.

甲状腺癌分子病理

异型增生分子特征

Abbreviations: EXPR: Expression (IHC); METH: Methylation (promoter); DEL: Deletion; OVERALL: overall alterations (Deletion+ Methylation);DYS: Dysplasia; HNSCC: Head and neck squamous cell carcinoma; H

NIAID Data Ecosystem40

SUTEAU V_JCEM supplemental data

资源简介：

相关数据集